/Companies

Oncobit

Zurich, CH · 1 known investors

Find your way into Oncobit

Sign up to see every warm intro you have to Oncobit

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncobit team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Oncobit provides molecular diagnostic solutions that enable clinicians to monitor cancer and optimize therapy selection through advanced genetic analysis of plasma samples.

Founders & leadership

CSClaudia Scheckel
Claudia ScheckelCEOClaudia Scheckel has worked in biomedical research for nearly two decades, initially in academia before becoming CEO of Oncobit, which develops molecular diagnostic solutions for cancer monitoring and therapy optimization.

Investors · 1

Funding

SEC filings, press & company announcements
  • Undisclosed amountPre-Series A RoundNov 2024
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Oncobit do?
Oncobit provides molecular diagnostic solutions that enable clinicians to monitor cancer and optimize therapy selection through advanced genetic analysis of plasma samples.
Who are Oncobit's investors?
Oncobit's investors include Kickfund.
Where is Oncobit headquartered?
Oncobit is headquartered in Zurich, CH.